Looking for signals and joining up reporting: UK MHRA takes a new approach to medical device incidents
This article was originally published in SRA
The UK Medicines and Healthcare Products Regulatory Agency is looking at smarter ways of managing an ever-rising workload in medical device adverse incidents. Elsewhere, it has high hopes for the integrated incident reporting system in England that is to be launched in 2014. Improved EU harmonization is also on the agenda, the agency’s group manager Tony Sant tells Ashley Yeo.
You may also be interested in...
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
The consensus among investors is that medtech has been the best-performing part of health care for the past three to four years, and investment levels remain good. Seemingly all-encompassing of late has been companies’ preoccupation with digital strategies, but there is a lot more to this unique industry than just digital.
With fewer than a hundred days left before the EU Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss in this week's podcast growing concerns by medtech industry members that they may not be ready in time to comply with the regulations and may inadvertently run afoul of them.